These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6270486)

  • 21. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4354-8. PubMed ID: 12505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.
    Creese I; Padgett L; Fazzini E; Lopez F
    Eur J Pharmacol; 1979 Jul; 56(4):411-2. PubMed ID: 477735
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased binding of [3H]apomorphine in caudate membranes after dopamine pretreatment in vitro.
    McManus C; Hartley EJ; Seeman P
    J Pharm Pharmacol; 1978 Jul; 30(7):444-7. PubMed ID: 27612
    [No Abstract]   [Full Text] [Related]  

  • 26. Binding of apomorphine to neural membranes.
    Hoss W; Reese JH; Smiley C
    J Neurosci Res; 1977; 3(4):257-66. PubMed ID: 615274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502.
    Closse A; Camps M; Wanner A; Palacios JM
    Brain Res; 1988 Feb; 440(1):123-32. PubMed ID: 2965955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible binding of [3H](-)N-chloroethylnorapomorphine to mammalian brain tissue.
    Baldessarini RJ; Kula NS
    Life Sci; 1983 Aug; 33(8):769-78. PubMed ID: 6193387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
    Arana GW; Baldessarini RJ; Kula NS
    Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
    Wreggett KA; Seeman P
    Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites.
    Morgan DG; Finch CE
    J Neurochem; 1986 May; 46(5):1623-31. PubMed ID: 2937884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]Clozapine is not a suitable radioligand for the labelling of D4 dopamine receptors in postmortem human brain.
    Flamez A; de Backer JP; Wilczak N; Vauquelin G; de Keyser J
    Neurosci Lett; 1994 Jul; 175(1-2):17-20. PubMed ID: 7970202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.
    Graham WC; Sambrook MA; Crossman AR
    Brain Res; 1993 Feb; 602(2):290-303. PubMed ID: 8095431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Binding of [3H] dihydroetorphine to opioid receptors in rat brain membrane].
    Wang DX; Qin BY
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):281-3. PubMed ID: 9812759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. I. Binding characteristics in rat brain membranes.
    Szücs M; Belcheva M; Simon J; Benyhe S; Tóth G; Hepp J; Wollemann M; Medzihradszky K
    Life Sci; 1987 Jul; 41(2):177-84. PubMed ID: 3037220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus.
    Schoemaker H
    Eur J Pharmacol; 1993 Oct; 242(3):R1-2. PubMed ID: 8281986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.